Tilray Brands Inc
TLRY: XNAS (USA)
| Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
|---|---|---|---|
| LOCK|&$QY$?& | LOCK|#Z | LOCK|Cxt<>? |
Tilray Earnings: Beverage Results Are a Drag on Otherwise Solid Performance From Cannabis
Tilray's fiscal third-quarter 2026 net revenue increased 11% to USD 207 million. The 19% revenue growth in the cannabis segment and 35% growth in the distribution segment offset a 24% decline in the beverage segment. Adjusted EBITDA margin expanded about 32 basis points to 5.2%.
